Fri, March 15, 2019
Thu, March 14, 2019
Wed, March 13, 2019
Tue, March 12, 2019
Mon, March 11, 2019
Fri, March 8, 2019
Thu, March 7, 2019
Wed, March 6, 2019
Tue, March 5, 2019
Mon, March 4, 2019
Fri, March 1, 2019
Thu, February 28, 2019
Wed, February 27, 2019
Tue, February 26, 2019
Mon, February 25, 2019
Fri, February 22, 2019
Thu, February 21, 2019
Wed, February 20, 2019
Tue, February 19, 2019
Fri, February 15, 2019
Thu, February 14, 2019
Wed, February 13, 2019

Alethia Young Maintained (SRPT) at Buy with Increased Target to $231 on, Feb 28th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-231-on-feb-28th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Alethia Young of Cantor Fitzgerald, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $217 to $231 on, Feb 28th, 2019.

Alethia has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $188 on, Tuesday, November 6th, 2018

Publication Contributing Sources